Syneron's elure Advanced Skin Lightening™ Products Wins 'BEST OF BEAUTY' in Allure Magazine

YOKNEAM, Israel, September 21, 2011 /PRNewswire/ --

- elure Advanced Skin Lightening Products captures the prestigious title of "The Big Breakthrough in Beauty" by Allure magazine for 2011

Syneron Medical Ltd. (NASDAQ: ELOS), http://www.syneron.com, the global leader in medical aesthetic products and technology, announced today it won the Allure magazine 2011 Best of Beauty award in the Big Breakthroughs category for both the elure Advanced Skin Lightening™ Lotion and the elure Advanced Lightening™ Night Cream.  

"We are extremely delighted and honored to receive this prestigious award from Allure, a publication we hold in the highest regard," said Louis P. Scafuri, Chief Executive Officer of Syneron. "elure further instills our commitment in pioneering innovative aesthetic applications for the face and body and puts us at the forefront of exciting technological advancements that aim to meet and exceed our physician partners' high standards."?  Dr. Shimon Eckhouse, Chairman of the Board of Syneron commented, "elure is an excellent example of Syneron's technology and product development strategy focused on bringing complete aesthetic solutions to our customers and to consumers. elure is the next generation in skin lightening products with an outstanding efficacy and safety profile proven in extended clinical trials."

According to Allure, most lighteners (including hydroquinone, the dermatologists' gold standard) are only able to address dark spots by blocking the production of melanin deep within the skin but for years, scientists have been looking for an ingredient that can dissolve hyperpigmentation right on the skin's surface-and the creators of Elure have done exactly that. "We finally have a way to dissolving melanin on the skin, which means we can achieve lightening much faster, without irritation," said Dr. Leslie Baumann, a board-certified dermatologist in Miami Beach, Florida who also served on elure's medical advisory board.

The two elure products will be featured in the October issue of Allure magazine, with a circulation over 1 million readers. The list can also be viewed on Allure.com: http://www.allure.com/beauty-products/best-of-beauty/2011/best-of-beauty-big-breakthroughs#slide=1

For more information about elure Advanced Skin Lightening Products visit http://www.elureskin.com or follow us on Facebook: http://www.facebook.com/elureskin.???

About Syneron Medical Ltd.

Syneron Medical Ltd. - a company devoted to real technology, real science and real results - is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US. The company markets and services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

elure™ is sold as a topical cosmetic intended to beautify your skin and cosmetics are not subject to evaluation by the FDA. All product information provided is intended to be for informational purposes only. The information about skin conditions provided herein does not constitute medical or pharmaceutical advice and should not be relied upon as a substitute for qualified medical consultation with health professionals.

Additional information can be found at http://www.syneron.com

Contacts:
Linda.Pavy@bm.com
+33-1-41-86-76-26

Syneron PR - pr@syneron.com

Asaf Alperovitz
Chief Financial Officer
+972-73-244-2283